Shell Asset Management Co. grew its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 61.6% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 51,925 shares of the company's stock after buying an additional 19,797 shares during the period. Shell Asset Management Co.'s holdings in Procter & Gamble were worth $8,273,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Nova Wealth Management Inc. acquired a new stake in shares of Procter & Gamble during the first quarter worth $26,000. Signature Resources Capital Management LLC lifted its stake in shares of Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock worth $28,000 after acquiring an additional 72 shares during the period. Quarry LP purchased a new stake in shares of Procter & Gamble in the first quarter valued at about $33,000. Mizuho Securities Co. Ltd. raised its holdings in Procter & Gamble by 566.7% during the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock worth $34,000 after purchasing an additional 170 shares in the last quarter. Finally, RMG Wealth Management LLC purchased a new stake in Procter & Gamble in the 2nd quarter valued at approximately $37,000. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Stock Performance
Shares of PG opened at $150.47 on Tuesday. The company has a market capitalization of $352.17 billion, a price-to-earnings ratio of 23.11, a PEG ratio of 4.02 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The company's 50 day simple moving average is $155.38 and its 200 day simple moving average is $159.84.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.
Insiders Place Their Bets
In other news, insider Balaji Purushothaman sold 490 shares of the business's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $74,592.70. Following the completion of the sale, the insider directly owned 12,616 shares of the company's stock, valued at $1,920,533.68. The trade was a 3.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Shailesh Jejurikar sold 3,986 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the transaction, the chief operating officer directly owned 46,899 shares in the company, valued at $7,139,434.77. This trade represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Several analysts have recently commented on PG shares. BNP Paribas reissued an "outperform" rating and issued a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. Wells Fargo & Company reduced their target price on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a report on Thursday, September 25th. Evercore ISI reaffirmed an "in-line" rating and set a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Weiss Ratings restated a "hold (c+)" rating on shares of Procter & Gamble in a research report on Saturday, September 27th. Finally, BNP Paribas Exane decreased their target price on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a research report on Tuesday, September 23rd. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $173.11.
Check Out Our Latest Report on PG
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.